Literature DB >> 22960554

Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney.

Maaike B van Werkhoven1, Jeffrey Damman, Mohamed R Daha, Christina Krikke, Harry van Goor, Willem J van Son, Jan-Luuk Hillebrands, Marcory C R F van Dijk, Marc A J Seelen.   

Abstract

AIMS: The complement system, and especially C5a, plays an important role in the pathophysiology of renal diseases and post-transplant renal injury. The two receptors for C5a are C5a receptor (C5aR) and C5a-like-receptor-2 (C5L2). Only renal C5aR expression has been reported, although exact localization and alterations in expression after transplantation are unknown. MATERIALS AND
RESULTS: Renal C5aR and C5L2 expression and localization were analyzed immunohistochemically. C5aR and C5L2 expression was analyzed in human kidney biopsies obtained from living donors and patients suffering from acute tubular necrosis, acute cellular and vascular rejection or IF/TA. C5aR was expressed in the thick ascending limb of Henle's loop and first part of the distal convoluted tubule (DCT). Under inflammatory conditions, C5aR was de novo expressed in proximal tubuli. C5L2 was expressed in the kidney and localized to DCT1, DCT2 and connecting tubule. Persistent distal tubular expression of both receptors was demonstrated after renal transplantation.
CONCLUSIONS: This study shows distinct renal expression patterns for C5aR and C5L2. Our findings suggest a functional role for renal C5L2 rather than being a C5a decoy receptor. Future studies focusing on renal C5a-C5aR interaction should take differential C5aR and C5L2 expression into account, alongside abundant C5aR expression on infiltrating cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960554     DOI: 10.1016/j.molimm.2012.08.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function.

Authors:  Bernd Schröppel; Peter S Heeger; Heather Thiessen-Philbrook; Isaac E Hall; Mona D Doshi; Francis L Weng; Peter P Reese; Chirag R Parikh
Journal:  Transplantation       Date:  2019-01       Impact factor: 4.939

Review 2.  The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.

Authors:  Ting Zhang; Malgorzata A Garstka; Ke Li
Journal:  J Immunol Res       Date:  2017-06-15       Impact factor: 4.818

Review 3.  Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.

Authors:  Rossana Franzin; Alessandra Stasi; Marco Fiorentino; Giovanni Stallone; Vincenzo Cantaluppi; Loreto Gesualdo; Giuseppe Castellano
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

4.  Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury.

Authors:  Giuseppe Castellano; Rossana Franzin; Fabio Sallustio; Alessandra Stasi; Barbara Banelli; Massimo Romani; Giuseppe De Palma; Giuseppe Lucarelli; Chiara Divella; Michele Battaglia; Antonio Crovace; Francesco Staffieri; Giuseppe Grandaliano; Giovanni Stallone; Pasquale Ditonno; Paolo Cravedi; Vincenzo Cantaluppi; Loreto Gesualdo
Journal:  Aging (Albany NY)       Date:  2019-07-08       Impact factor: 5.682

5.  Role of C5aR1 and C5L2 Receptors in Ischemia-Reperfusion Injury.

Authors:  Carlos Arias-Cabrales; Eva Rodriguez-Garcia; Javier Gimeno; David Benito; María José Pérez-Sáez; Dolores Redondo-Pachón; Anna Buxeda; Carla Burballa; Marta Crespo; Marta Riera; Julio Pascual
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

6.  Epithelial C5aR1 Signaling Enhances Uropathogenic Escherichia coli Adhesion to Human Renal Tubular Epithelial Cells.

Authors:  Yun Song; Kun-Yi Wu; Weiju Wu; Zhao-Yang Duan; Ya-Feng Gao; Liang-Dong Zhang; Tie Chong; Malgorzata A Garstka; Wuding Zhou; Ke Li
Journal:  Front Immunol       Date:  2018-05-01       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.